SEC 13F Intelligence

Caisse De Depot Et Placement Du Quebec / REGN

Caisse De Depot Et Placement Du Quebec’s Regeneron Pharmaceuticals Position

Does Caisse De Depot Et Placement Du Quebec own Regeneron Pharmaceuticals (REGN)? Yes — 329.0K shares worth $254M (+0.41% of its 13F portfolio) as of Q1 2026, down from 342.3K shares the prior filed quarter.

Position Value
$254M
Q1 2026
Shares
329.0K
% of Portfolio
+0.41%
Quarters Held
30
currently held

Position History REGN

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $4MQ2 ’19: $3MQ3 ’19: $3MQ4 ’19: $4MQ4 ’19Q1 ’20: $8MQ2 ’20: $7MQ3 ’20: $6MQ4 ’20: $4MQ4 ’20Q1 ’21: $3MQ2 ’21: $22MQ3 ’21: $74MQ4 ’21: $117MQ4 ’21Q1 ’22: $114MQ2 ’22: $65MQ3 ’22: $86MQ4 ’22: $77MQ4 ’22Q1 ’23: $136MQ2 ’23: $130MQ3 ’23: $122MQ4 ’23: $229MQ4 ’23Q1 ’24: $219MQ2 ’24: $146MQ3 ’24: $205MQ4 ’24: $221MQ4 ’24Q1 ’25: $141MQ2 ’25: $113MQ3 ’25: $260MQ4 ’25: $264MQ4 ’25Q1 ’26: $254Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026329.0K$254M+0.41%
Q4 2025342.3K$264M+0.45%
Q3 2025462.5K$260M+0.47%
Q2 2025214.7K$113M+0.24%
Q1 2025222.6K$141M+0.30%
Q4 2024310.2K$221M+0.46%
Q3 2024194.6K$205M+0.41%
Q2 2024138.8K$146M+0.35%
Q1 2024228.0K$219M+0.53%
Q4 2023260.2K$229M+0.58%
Q3 2023148.1K$122M+0.35%
Q2 2023180.3K$130M+0.34%
Q1 2023165.2K$136M+0.39%
Q4 2022107.4K$77M+0.24%
Q3 2022125.5K$86M+0.25%
Q2 2022109.8K$65M+0.18%
Q1 2022163.7K$114M+0.27%
Q4 2021184.5K$117M+0.25%
Q3 2021122.5K$74M+0.16%
Q2 202139.7K$22M+0.05%
Q1 20217.2K$3M+0.01%
Q4 20207.5K$4M+0.01%
Q3 202010.7K$6M+0.02%
Q2 202011.4K$7M+0.02%
Q1 202015.5K$8M+0.02%
Q4 201911.2K$4M+0.01%
Q3 201911.1K$3M+0.01%
Q2 201910.8K$3M+0.01%
Q1 201910.0K$4M+0.01%
Q4 20188.7K$3M+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Caisse De Depot Et Placement Du Quebec’s full portfolio or all institutional holders of REGN.